Cytarabine and Post procedural complication - a phase IV clinical study of FDA data

Summary:

Post procedural complication is reported as a side effect among people who take Cytarabine (cytarabine), especially for people who are female, 10-19 old, have been taking the drug for < 1 month also take Methotrexate, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Post procedural complication when taking Cytarabine. It is created by eHealthMe based on reports of 65,319 people who have side effects when taking Cytarabine from the FDA, and is updated regularly.

What is Cytarabine?

Cytarabine has active ingredients of cytarabine. It is often used in acute myelogenous leukemia (aml) - adult. eHealthMe is studying from 65,358 Cytarabine users. Check the latest studies of Cytarabine.

What is Post procedural complication?

Post procedural complication is found to be associated with 1,089 drugs and 1,362 conditions by eHealthMe. Check the latest studies of Post procedural complication.

On Jul, 12, 2026

65,319 people reported to have side effects when taking Cytarabine.
Among them, 56 people (0.09%) have Post procedural complication.

Could Cytarabine cause Post procedural complication?

Among these 56 people:

How long have people been on Cytarabine when they have Post procedural complication? *

What is the gender of people who have Post procedural complication when taking Cytarabine? *

female: 52.73 %
male: 47.27 %

What is the age of people who have Post procedural complication when taking Cytarabine? *

What are other drugs people take besides Cytarabine? *

What are other side effects people have besides Post procedural complication? *

Febrile Neutropenia (fever with reduced white blood cells): 10 people, 17.86%
Fever: 9 people, 16.07%
Staphylococcal Infection (an infection with staphylococcus bacteria): 8 people, 14.29%
Thrombocytopenia (decrease of platelets in blood): 7 people, 12.50%
Hypotension (abnormally low blood pressure): 7 people, 12.50%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 6 people, 10.71%
Septic Shock (shock due to blood infection): 6 people, 10.71%
Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 6 people, 10.71%
Pleural Effusion (water on the lungs): 5 people, 8.93%
Respiratory Distress (difficulty in breathing): 5 people, 8.93%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 15 people, 26.79%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 8.93%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 3.57%
Bone Marrow Conditioning Regimen: 2 people, 3.57%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 3.57%
Pneumonia: 2 people, 3.57%
Acute Promyelocytic Leukaemia (cancer of the blood and bone marrow): 1 person, 1.79%
Affective Disorder (mental disorder): 1 person, 1.79%
Aplastic Anemia: 1 person, 1.79%
Fungal Infection: 1 person, 1.79%

* Approximation only. Some reports may have incomplete information.

Do you take Cytarabine and have Post procedural complication?

- Check whether Post procedural complication is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cytarabine:

Cytarabine (65,358 reports)

Browse all side effects of Cytarabine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Post procedural complication:

Post procedural complication (1,089 drugs)

Browse all the conditions that are associated with Post procedural complication:

Post procedural complication (1,362 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cytarabine (the active ingredients of Cytarabine) and Cytarabine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.